IP Verse

Monoclonal Antibodies Against Nkg2A

Patent No. EP1831258 (titled "Monoclonal Antibodies Against Nkg2A") was filed by Innate Pharma on Dec 27, 2005. The application was issued on Jun 7, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERCK SHARP & DOHMEJul 13, 2016BOHLES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1831258

INNATE PHARMA
Application Number
EP05825249A
Filing Date
Dec 27, 2005
Status
Patent Maintained As Amended
May 5, 2023
Publication Date
Jun 7, 2023
External Links
Slate, Register , Google Patents